Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin.
- Published In:
- Thrombosis research, 129(5), 652-9 (2012)
- Authors:
- Stupnisek, Mirjana(5), Franjic, Sandra, Drmic, Domagoj(20), Hrelec, Masa, Kolenc, Danijela, Radic, Bozo, Bojic, Davor, Vcev, Aleksandar, Seiwerth, Sven, Sikiric, Predrag
- Database ID:
- RPEP-02078
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02078APA
Stupnisek, Mirjana; Franjic, Sandra; Drmic, Domagoj; Hrelec, Masa; Kolenc, Danijela; Radic, Bozo; Bojic, Davor; Vcev, Aleksandar; Seiwerth, Sven; Sikiric, Predrag. (2012). Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin.. Thrombosis research, 129(5), 652-9. https://doi.org/10.1016/j.thromres.2011.07.035
MLA
Stupnisek, Mirjana, et al. "Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin.." Thrombosis research, 2012. https://doi.org/10.1016/j.thromres.2011.07.035
RethinkPeptides
RethinkPeptides Research Database. "Pentadecapeptide BPC 157 reduces bleeding time and thrombocy..." RPEP-02078. Retrieved from https://rethinkpeptides.com/research/stupnisek-2012-pentadecapeptide-bpc-157-reduces
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.